1-4 of 4
Mandy Wagner
Close
Sort by
Journal Articles

Survivin Is Negatively Regulated by Early Growth Response (Egr)-1 Transcription Factor in Acute Myeloid Leukemia.

Ingo Tamm, MD, Karin Schmelz, Ph.D., Bernd Dörken, M.D., Mandy Wagner, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 1943.
https://doi.org/10.1182/blood.V108.11.1943.1943
Published: 2006
Journal Articles

No Impact of Adverse Karyotype on Outcome after Allogeneic Stem Cell Transplantation in Patients with High-Risk Acute Lymphoblastic Leukemia.

Ingo Tamm, MD, Gero Massenkeil, M.D., Mandy Wagner, Ph.D., Theis Terwey, M.D., Christoph Lutz, M.D., Stefan Neuburger, M.D., Christiane Bommert, M.D., Bernd Dörken, M.D., Renate Arnold, M.D.
Journal: Blood
Blood (2006) 108 (11): 3152.
https://doi.org/10.1182/blood.V108.11.3152.3152
Published: 2006
Journal Articles

Decitabine: Where Is the Target?.

Ingo Tamm, MD, Nicole Sattler, PhD, Mandy Wagner, PhD, Michael Lübbert, MD, Philipp leCoutre, MD, Bernd Dörken, MD, Karin Schmelz, PhD
Journal: Blood
Blood (2005) 106 (11): 495.
https://doi.org/10.1182/blood.V106.11.495.495
Published: 2005
Journal Articles

5′-AZA-2′-Deoxycytidine Induces p21/WAF Expression by Demethylation of p73 Leading to p53-Independent Apoptosis in Myeloid Leukemia.

Ingo Tamm, M.D., Mandy Wagner, Bernd Dörken, M.D., Karin Schmelz, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 1166.
https://doi.org/10.1182/blood.V104.11.1166.1166
Published: 2004